CCL2 and COVID-19: Of additional interest in the context of COVID-19, FYCO1 is associated with the levels of the monocyte chemoattractant protein-1 (Ahola-Olli et al., 2017; Buniello et al., 2019), which contributes to COVID-19 through hyperinflammation (Mehta et al., 2020).